Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines CCRN Q1 2026 Earnings EPS Beats Estimates as Loss Narrows in Soft Staffing Market FTK Q1 2026 Earnings EPS Misses Estimates as Stock Declines GBFH Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises Slightly EML Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick IOR Q4 2024 Earnings Positive Earnings Amid Limited Market Visibility